|
RFA on the Development of Mouse Phenotypic Screens
for Heart, Lung, and Blood Diseases
The aim of this RFA is to solicit research grant applications for the
development of phenotypic screening methods in the mouse for heart,
lung, and blood diseases and sleep disorders. The purpose of the RFA is
to stimulate research on the phenotypic screening of mice for heart,
lung, blood and sleep disorders in order to accelerate the pace at which
mice with heritable disorders that are models of human disease produced
through either targeted or random mutagenesis are made available to the
research community for further investigation or application. This RFA
will support investigators to (1) develop mouse screening and phenotype
characterization protocols, particularly those that can be used for high
throughput analysis of mouse phenotypes; (2) provide for the systematic
validation of these screening protocols against normal inbred mouse
strains and genetically altered mouse strains that approximate the
disease of interest; and (3) provide for the timely dissemination of
information and methodologies to the scientific community. $4.5 million
is available for the first year of this initiative, which should support
approximately 10 projects for up to four years duration. The
application receipt date is September 15, 1999, and the anticipated
award date is July 1, 2000.
Additional information about this RFA can be found at
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-99-010.html
|